The Triana Group announces the completion of a proprietary feasibility study of Augmented Reality Applications in the Healthcare Sector.

Within this sector, the study focuses on the long -term rehab equipment and solutions that are being rolled out to the 95,000 physical therapy offices and rehab centers, 5,600+ hospitals, 80,000 nursing homes and long-term care, as well as patients’ homes. While still fragmented, these segments targeted by augmented reality innovators are experiencing favorable changes via mergers & acquisitions, new reimbursement models such as bundled payments and population health management, and integration of new information technology.

The study’s methodology is primarily based on interviews with users and buyers, benchmarking of 12 short-listed solutions providers based on publicly available and proprietary sources, and analysis of relevant corporations and organizations (including discussions with clinicians, healthcare management, insurance, reimbursement, regulatory, clinical studies, sales.)

The Triana Group study’s insights have informed our clients at the CEO-level and board level about market potential, competitive positioning, revenue projections, go-to-market options, and strategic development opportunities in the United States healthcare market.

Augmented Reality in Healthcare Study Content

(all actual content confidential)

Executive Summary

Methodology

Market Size

  • Increasing number of establishments
  • Growing employment
  • Market size, per year
  • Market projections through 2018
  • Volume, patient visits and number of patients

Economics of a clinical site

  • Increased average revenue
  • Decreased profitability due to compressed reimbursement rates
  • Average staff per establishment
  • Average wages per category of personnel
  • Metrics and benchmarks in the sector

Market Segmentation

  • Segmentation by client size
  • Consolidation trends and key M&A movements
  • Profiles and strategy of key players in key segments
  • Segmentation by type of organization (including independent sites, chains, hospitals and ACOs, etc.)
  • Drivers and Barriers to augmented reality adoption, per segment
  • Segmentation by disease area
  • Drivers and Barriers to augmented reality adoption, by patient category
  • Prioritization of segments, based on study and expert interviews
  • Segmentation by geography

Market Potential

  • The issue of patient adherence
  • Changing clinicians’ attitudes towards technology
  • Review of augmented reality coverage in clinical and professional magazines
  • Cycle of augmented reality adoption, based on clinicians’ survey results (includes percentage of early adopters, early majority, late majority, laggards)
  • Rate of innovation diffusion (examples based on lower back-pain and post-stroke)
  • Market feedback based on demo results and in-depth interviews with users, buyers, and key opinion leaders
  • Market validation
  • Key trends and drivers
  • Key issues and barriers to be addressed

Competitive Landscape

  • General competitive assessment (NB: Actual list of companies and benchmarking are confidential)
  • Positioning maps
  • Benchmarking table
  • Competitors profiles and strategies (includes large established players, rapidly growing well funded start-ups, and emerging innovators.)
  • Detection of small players potential targets for acquisition or investment

Positioning Options

  • Results of demos & interviews with clinicians
  • Product evaluation
  • Decision tree and product roadmap options

Pricing Strategy

  • Methodology and criteria used
  • Buyers’ feedback about price points and perceived value
  • Reimbursement codes analysis
  • Comparative pricing
  • Revenue model options & scenarios (including outline of ROI for buyers)
  • Competitive benchmarks
  • Targeted payors

Financial Projections

  • Proprietary, detailed 5-year revenue projections
  • Revenue model / scenario builder (based on key revenue drivers and metrics)

Distribution Channels, Customer Support & Maintenance

  • Competitors distribution channels, selected profiles
  • Identification of regional and national distributors, and value proposition
  • Identification of regional sales agencies
  • Identification of potential strategic collaborations
  • Identification of targets for potential “mini-M&A”

Market Access Requirements

  • Intellectual property analysis
  • Clinical research requirements
  • Outcome measurement and evidence-based treatments
  • Professional associations’ focus
  • Clinical research publications benchmarks
  • Competitors’ ongoing clinical research practices
  • Review of FDA’s registered clinical trials
  • Identification of potential pilots, reference sites, and clinical research collaborations in the US
  • FDA registration plan, budget, and short-listed regulatory partner
  • Reimbursement plan (reimbursement codes analysis, reimbursement consultants pre-selection, next-steps)
  • Branding requirements
  • Analysis of competitors marketing and communications strategies
  • Annual calendar of national and regional conferences & tradeshows relevant to the sector
  • Proposed annual conferences and communication plan
  • Marketing options and budgets
  • Digital strategy (review of relevant digital landscape and recommendations)

Sources and Databases

Want to know more?

This study is proprietary and its actual content may not be disclosed. However, if this or other technology markets may be of interest to your company, contact us